Author:
Kitayama M.,McDonald J.,Barnes T. A.,Calo’ G.,Guerrini R.,Rowbotham D. J.,Lambert D. G.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Reference35 articles.
1. Albrecht E, Samovilova NN, Oswald S, Baeger I, Berger H (1998) Nociceptin (orphanin FQ): high-affinity and high-capacity binding site coupled to low-potency stimulation of guanylyl-5¢-O-(gamma-thio)-triphosphate binding in rat brain membranes. J Pharmacol Exp Ther 286:896–902
2. Bigoni R, Calo G, Guerrini R, Strupish JW, Rowbotham DJ, Lambert DG (2001) Effects of nociceptin and endomorphin 1 on the electrically stimulated human vas deferens. Br J Clin Pharmacol 51:355–358
3. Calo G, Bigoni R, Rizzi A, Guerrini R, Salvadori S, Regoli D (2000) Nociceptin/orphanin FQ receptor ligands. Peptides 21:935–947
4. Chang M, Peng YL, Dong SL, Han RW, Li W, Yang DJ, Chen Q, Wang R (2005) Structure–activity studies on different modifications of nociceptin/orphanin FQ: identification of highly potent agonists and antagonists of its receptor. Regul Pept 130:116–122
5. Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献